GLP-1 acts on the GLP-1R, activating multiple intracellular signaling pathways, including the cAMP/PKA pathway, the PI3K/Akt signaling pathway, and pathways related to anti-inflammatory and anti-oxidative stress responses, among others
Minimizing Side Effects One of the most frequently cited reasons for microdosing GLP-1 drugs, as mentioned above, is the desire to minimize side effects
The cardiovascular benefits of weekly injected GLP-1 receptor agonists have been proven in SUSTAIN-6 (Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes), REWIND (Researching Cardiovascular Events with a Weekly Incretin in Diabetes) and The Harmony outcomes trials
Seven to nine hours of quality sleep supports hormone balance, muscle recovery, appetite regulation, and mental health
Most studies have reported that GLP-1RAs have renoprotective effects
The Future of GLP-1 Medications in Weight Management Innovations in Delivery Methods As technology advances, new delivery methods for GLP-1 medications are emerging, enhancing patient convenience and compliance
